These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35946912)

  • 1. The Effect of Hesperidin and Diosmin Individually or in Combination on Metabolic Profile and Neuropathy among Diabetic Patients with Metabolic Syndrome: A Randomized Controlled Trial.
    Osama H; Hamed EO; Mahmoud MA; Abdelrahim MEA
    J Diet Suppl; 2023; 20(5):749-762. PubMed ID: 35946912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Yari Z; Movahedian M; Imani H; Alavian SM; Hedayati M; Hekmatdoost A
    Eur J Nutr; 2020 Sep; 59(6):2569-2577. PubMed ID: 31844967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination.
    Tanaka T; Makita H; Kawabata K; Mori H; Kakumoto M; Satoh K; Hara A; Sumida T; Fukutani K; Tanaka T; Ogawa H
    Carcinogenesis; 1997 Apr; 18(4):761-9. PubMed ID: 9111212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
    Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
    Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination.
    Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A; Sumida T; Fukutani K; Tanaka T; Ogawa H
    Cancer Res; 1997 Jan; 57(2):246-52. PubMed ID: 9000563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice.
    Yang M; Tanaka T; Hirose Y; Deguchi T; Mori H; Kawada Y
    Int J Cancer; 1997 Nov; 73(5):719-24. PubMed ID: 9398052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
    Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Effect of Loratadine versus Diosmin/Hesperidin Combination on Vinca Alkaloids-Induced Neuropathy: A Randomized Controlled Clinical Trial.
    Kamal N; Abdallah MS; Abdel Wahed E; Sabri NA; Fahmy SF
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study.
    Corsale I; Carrieri P; Martellucci J; Piccolomini A; Verre L; Rigutini M; Panicucci S
    Int J Colorectal Dis; 2018 Nov; 33(11):1595-1600. PubMed ID: 29934701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
    Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
    J Clin Pharm Ther; 2006 Aug; 31(4):375-83. PubMed ID: 16882108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS.
    Crespo ME; Gálvez J; Cruz T; Ocete MA; Zarzuelo A
    Planta Med; 1999 Oct; 65(7):651-3. PubMed ID: 10575379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of diosmin against diabetic neuropathy in experimental rats.
    Jain D; Bansal MK; Dalvi R; Upganlawar A; Somani R
    J Integr Med; 2014 Jan; 12(1):35-41. PubMed ID: 24461593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin.
    Tanaka T; Makita H; Kawabata K; Mori H; Kakumoto M; Satoh K; Hara A; Sumida T; Tanaka T; Ogawa H
    Carcinogenesis; 1997 May; 18(5):957-65. PubMed ID: 9163681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of diosmin and hesperidin on capillary blood flow of upper limbs in patients with secondary Raynaud's syndrome].
    Zudin AM; Gritsenko AG; Hadzhishvili IT
    Khirurgiia (Mosk); 2017; (5):60-66. PubMed ID: 28514385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Citrus Flavonoids Against Microvascular Damage Induced by Hypoperfusion and Reperfusion in Rat Pial Circulation.
    Mastantuono T; Battiloro L; Sabatino L; Chiurazzi M; Di Maro M; Muscariello E; Colantuoni A; Lapi D
    Microcirculation; 2015 Jul; 22(5):378-90. PubMed ID: 25944567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose vitamin D supplementations improve peripheral diabetic neuropathy? A before-after clinical trial.
    Ghadiri-Anari A; Mozafari Z; Gholami S; Khodaei SA; Aboutorabi-Zarchi M; Sepehri F; Nadjarzade A; Rahmanian M; Namiranian N
    Diabetes Metab Syndr; 2019; 13(1):890-893. PubMed ID: 30641826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diosmin/hesperidin: a cooperating tandem, or is diosmin crucial and hesperidin an inactive ingredient only?].
    Karetová D; Suchopár J; Bultas J
    Vnitr Lek; 2020; 66(2):97-103. PubMed ID: 32942884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Analysis and Intervention Study on Disturbance of Lipid Metabolism and Diabetic Peripheral Neuropathy.
    Wang W; Li X; Ren Y
    Comput Math Methods Med; 2022; 2022():2579692. PubMed ID: 35242203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flaxseed and/or hesperidin supplementation in metabolic syndrome: an open-labeled randomized controlled trial.
    Yari Z; Cheraghpour M; Hekmatdoost A
    Eur J Nutr; 2021 Feb; 60(1):287-298. PubMed ID: 32296931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.
    Cazaubon M; Benigni JP; Steinbruch M; Jabbour V; Gouhier-Kodas C
    Vasc Health Risk Manag; 2021; 17():591-600. PubMed ID: 34556990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.